GTC Biotherapeutics (fka GTCB)

[biopearl]

Dew, I had hoped that TEVA would be "the one" given the Israel's propensity for audacity. Dissapointing for us. Since the hold up might represent skepticism re the platform itself particularly re regulation and approval from the FDA (US Atryn approval might change all that), overseas markets with less regulation (?parts of Asia) and particularly markets in India and other so called emerging countries with advancing technologies might make for more attractive partners and markets at this point. Maybe Dr. Ready is "the one". What are your thoughts? Regards, bp